Ratings Biotrend Cevre ve Enerji Yatirimlari

Equities

BIOEN

TREBION00012

Delayed Borsa Istanbul Other stock markets 07:19:45 2024-06-05 am EDT			5-day change	1st Jan Change
19.06 ^TRY	-1.85%		+13.04%	+10.87%

May. 17	Biotrend Cevre ve Enerji Yatirimlari A.S. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Biotrend Cevre ve Enerji Yatirimlari A.S. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Strengths

The prospective high growth for the next fiscal years is among the main assets of the company
The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
The company is one of the best yield companies with high dividend expectations.
Over the last twelve months, the sales forecast has been frequently revised upwards.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Consensus analysts have strongly revised their opinion of the company over the past 12 months.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Electric Utilities

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
BIOTREND CEVRE VE ENERJI YATIRIMLARI	+10.87%	298M	-	C
CHONGQING SANFENG ENVIRONMENT GROUP CORP., LTD.	+16.11%	2.02B		-
TPI POLENE POWER	-3.53%	752M		B-
MONTAUK RENEWABLES, INC.	-41.53%	740M		-
ABSOLUTE CLEAN ENERGY	-11.11%	374M	-	C+
CHINA EVERBRIGHT GREENTECH LIMITED	-46.15%	180M		-
TPC POWER HOLDING	+15.83%	76.1M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes